URSODEOXYCHOLIC ACID clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial
This study compares two treatments, ursodeoxycholic acid and steroids, for liver inflammation caused by cancer immunotherapy. It wants to see which treatment helps liver function improve by at least 25% within 21 days.
For: Cholestatic hepatitis induced by immune checkpoint inhibitors (ICIs)France - Active not recruitingPHASE4
Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus
This study compares two medicines, Ursodeoxycholic Acid and Metformin, for treating diabetes that starts during pregnancy (gestational diabetes). We want to see which one works better at controlling blood sugar in women who are overweight or obese and need medicine for their diabetes.
For: Gestational DiabetesUnited Kingdom - AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of Ursodeoxycholic Acid as a new therapy for the treatment of hepatorenal polycystic diseases, genetic study and determination of prognostic biomarkers.
This study is testing a medication called Ursodeoxycholic Acid for polycystic diseases affecting the liver and kidneys. Researchers want to see if it can shrink cysts and improve health. It's an early-stage study, focusing on safety and how well the treatment works in a small group of people.
For: Hepatorenal polycystic diseasesSpain